pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,097 catalysts · 3,288 8k filing · 2,079 grant · 1,097 approval · 1,000 device adverse event · 800 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 118 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×from 2026-01-14×clear all
type
  • 8k filing3,288
  • grant2,079
  • approval1,097
  • device adverse event1,000
  • device 510k800
  • earnings584
device pma
573
  • device recall291
  • recall215
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Jan 12, 2026

    50
    ›Jan 14, 2026approval212d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoMEN'S ROGAINE (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    ›Jan 14, 2026approval212d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗
    ›Jan 14, 2026approval212d agoROGAINE (FOR WOMEN) (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    ›Jan 14, 2026approval212d agoFLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (FLUCONAZOLE) — FDA approvalDiflucan

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →Diflucan →fda approvals ↗
    ›Jan 14, 2026approval212d agoAVTOZMA (TOCILIZUMAB-ANOH) — FDA approvalAVTOZMA

    Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →AVTOZMA →fda approvals ↗
    ›Jan 14, 2026approval212d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗
    ›Jan 14, 2026approval212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: LAURUS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoGLEEVEC (IMATINIB MESYLATE) — FDA approvalImatinib Mesylate Shilpa

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →Imatinib Mesylate Shilpa →fda approvals ↗
    ›Jan 14, 2026approval212d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

    Sponsor: LAURUS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoELTROMBOPAG OLAMINE — FDA approvalELTROMBOPAG OLAMINE

    Sponsor: SOMERSET THERAPS LLC. Form: TABLET

    full page →ELTROMBOPAG OLAMINE →fda approvals ↗
    ›Jan 14, 2026approval212d agoELTROMBOPAG OLAMINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoLIRAGLUTIDE — FDA approvalNovo Nordisk Inc

    Sponsor: ORBICULAR. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoTOREMIFENE CITRATE — FDA approvalTOREMIFENE CITRATE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →TOREMIFENE CITRATE →fda approvals ↗
    ›Jan 14, 2026approval212d agoMYCOPHENOLATE SODIUM — FDA approvalmycophenolate sodium DR

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →mycophenolate sodium DR →fda approvals ↗
    ›Jan 14, 2026approval212d agoROGAINE EXTRA STRENGTH (FOR MEN) (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoSITAGLIPTIN PHOSPHATE — FDA approvalSITAGLIPTIN PHOSPHATE

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →SITAGLIPTIN PHOSPHATE →fda approvals ↗
    ›Jan 14, 2026approval212d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Jan 14, 2026approval212d agoMETHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approvalPFIZER INC

    Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoMETHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approvalPFIZER INC

    Sponsor: PHARMACHEMIE BV. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 14, 2026approval212d agoANAGRELIDE HYDROCHLORIDE — FDA approvalANAGRELIDE HYDROCHLORIDE

    Sponsor: RISING. Form: CAPSULE. Route: ORAL

    full page →ANAGRELIDE HYDROCHLORIDE →fda approvals ↗
    ›Jan 15, 2026approval211d agoOSELTAMIVIR PHOSPHATE — FDA approvalOSELTAMIVIR PHOSPHATE

    Sponsor: AJANTA PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

    full page →OSELTAMIVIR PHOSPHATE →fda approvals ↗
    ›Jan 15, 2026approval211d agoREZUROCK (BELUMOSUDIL MESYLATE) — FDA approvalbelumosudil mesylate

    Sponsor: KADMON PHARMS LLC. Form: TABLET. Route: ORAL

    full page →belumosudil mesylate →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoOTULFI (USTEKINUMAB-AAUZ) — FDA approvalOTULFI

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →OTULFI →fda approvals ↗
    ›Jan 15, 2026approval211d agoNAPROXEN SODIUM — FDA approvalNAPROXEN SODIUM

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Jan 15, 2026approval211d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 15, 2026approval211d agoFILKRI (FILGRASTIM-LAHA) — FDA approvalfilgrastim biosimilar

    Sponsor: ACCORD BIOPHARMA INC.. Form: INJECTABLE. Route: INJECTION

    full page →filgrastim biosimilar →fda approvals ↗
    ›Jan 15, 2026approval211d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 15, 2026approval211d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMacleods Pharmaceuticals Ltd

    Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoTEPADINA AND SODIUM CHLORIDE (THIOTEPA) — FDA approvalRevalesio Corp

    Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoOXALIPLATIN — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: SHANDONG. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 15, 2026approval211d agoALVAIZ (ELTROMBOPAG CHOLINE) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 16, 2026approval210d agoZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalloncastuximab tesirine

    Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION

    full page →loncastuximab tesirine →fda approvals ↗
    ›Jan 16, 2026approval210d agoBRIUMVI (UBLITUXIMAB-XIIY) — FDA approvalublituximab

    Sponsor: TG THERAPEUTICS, INC. Form: INJECTABLE. Route: INTRAVENOUS

    full page →ublituximab →fda approvals ↗
    ›Jan 16, 2026approval210d agoLEQEMBI (LECANEMAB-IRMB) — FDA approvallecanemab

    Sponsor: EISAI INC. Form: INJECTABLE. Route: INJECTION

    full page →lecanemab →fda approvals ↗
    ›Jan 16, 2026approval210d agoRYKINDO (RISPERIDONE) — FDA approvalDelpor Inc

    Sponsor: SHANDONG LUYE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Jan 16, 2026approval210d agoIMPLANON (ETONOGESTREL) — FDA approvaletonogestrel CR

    Sponsor: ORGANON. Form: IMPLANT. Route: IMPLANTATION

    full page →etonogestrel CR →fda approvals ↗
    ›Jan 16, 2026approval210d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

    Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗
    ›Jan 16, 2026approval210d agoLOSARTAN POTASSIUM — FDA approvalLOSARTAN POTASSIUM

    Sponsor: HIKMA. Form: TABLET. Route: ORAL

    full page →LOSARTAN POTASSIUM →fda approvals ↗
    ← prev
    page 1 of 22
    next →
    $COLL27.87+8.44%
    $MANE111.01+1.80%
    $NVS151.72-0.39%
    $AMRX17.73+0.42%
    $PFE26.80+1.86%
    $PFE26.80+1.86%
    $COLL27.87+8.44%
    $MANE111.01+1.80%
    $MANE111.01+1.80%
    $COLL27.87+8.44%
    $COLL27.87+8.44%
    $ADCT1.0500-5.41%
    $COLL27.87+8.44%
    $TGTX48.01-3.01%
    $ABVC
    $COLL27.87+8.44%
    $COLL27.87+8.44%
    $COLL27.87+8.44%
    $OGN13.72+0.44%